review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1015966486 |
P356 | DOI | 10.2165/00003495-198400282-00002 |
P698 | PubMed publication ID | 6098436 |
P2093 | author name string | P. B. Molinoff | |
P2860 | cites work | Beta-receptors in orthostatic hypotension | Q72906968 |
Endogenous Agonist Regulation of α-Adrenoceptors in Man | Q72917437 | ||
Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects | Q72925338 | ||
Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver | Q79028501 | ||
On some physiological actions of ergot | Q24544497 | ||
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding | Q28216206 | ||
Selective blockade of adrenoceptive beta receptors in the heart | Q28240967 | ||
Beta adrenergic receptor binding in membrane preparations from mammalian brain | Q28284038 | ||
The contribution of extraneuronal uptake to the trachea-blood vessel selectivity of beta-adrenoceptor stimulants in vitro in guinea-pigs | Q28316349 | ||
Carazolol, an extremely potent β-adrenergic blocker: Binding to β-receptors in brain membranes | Q28317542 | ||
Mechanism of propranolol withdrawal phenomena | Q28326513 | ||
Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. | Q34285327 | ||
Inositol phospholipids and cell surface receptor function | Q34486299 | ||
Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites | Q34505907 | ||
Alpha-Adrenergic Receptor Identification by [ 3 H]Dihydroergocryptine Binding | Q34700574 | ||
Differentiation of Receptor Systems activated by Sympathomimetic Amines | Q34706728 | ||
Photoaffinity labeling of the beta-adrenergic receptor | Q34708183 | ||
The importance of calcium ions for the regulation of guanosine 3':5'-cyclic monophosphage levels | Q34754435 | ||
A study of the adrenotropic receptors | Q34854653 | ||
Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding | Q35076839 | ||
Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase | Q35089912 | ||
Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells | Q40129485 | ||
(+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes | Q40159857 | ||
Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants | Q40184773 | ||
Comparison of beta adrenergic receptor subtypes in mammalian tissues | Q40275448 | ||
Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol | Q41553075 | ||
Proposed mechanism of cholinergic action in smooth muscle | Q41599190 | ||
Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes | Q41949109 | ||
Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro | Q42121005 | ||
Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding | Q43472429 | ||
Withdrawal of propranolol and myocardial infarction | Q43724281 | ||
Propranolol withdrawal and thyroid hormones in patients with essential hypertension | Q45259084 | ||
Stereospecific (3H)(minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase | Q45263477 | ||
Drug-induced desensitization of beta adrenergic receptors | Q46620347 | ||
(+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. | Q46762710 | ||
Acummulation of cyclic adenosine 3', 5'-monophosphate in cerebral cortical slices from rat and mouse: stimulatory effect of alpha- and beta-adrenergic agents and adenosine | Q48622861 | ||
Adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices: effects of alpha- and beta-adrenergic agents, histamine, serotonin and adenosine | Q48636565 | ||
Characterization of the adrenergic receptors mediating a rise in cyclic 3'-5'-adenosine monophosphate in rat cerebral cortex | Q48662594 | ||
Observations on recent increase in mortality from asthma | Q49214529 | ||
Investigation into use of drugs preceding death from asthma | Q49214673 | ||
Myocardial infarction after propranolol withdrawal | Q53739155 | ||
(-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells | Q55491260 | ||
Cyclic 3′,5′-Adenosine Monophosphate in Human Blood Platelets | Q59095458 | ||
Is phosphatidic acid a calcium ionophore under neurohumoral control? | Q59095527 | ||
[125I]BE 2254, a new high affinity radioligand for α1-adrenoceptors | Q59201526 | ||
Iodohydroxybenzylpindolol: preparation, purification, localization of its iodine to the indole ring, and characterization as a partial agonist | Q59645513 | ||
Abrupt Withdrawal of Cardiovascular Drugs | Q66851020 | ||
Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system | Q66984353 | ||
The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine) | Q68717247 | ||
Withdrawal of propranolol and myocardial infarction | Q69997580 | ||
Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site | Q70053461 | ||
Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects | Q70749225 | ||
Differentiation of receptors responsive to isoproterenol | Q72314142 | ||
Multiple central WB-4101 binding sites and the selectivity of prazosin | Q72427074 | ||
Role of alpha 1 adrenoceptors in the turnover of phosphatidylinositol and of alpha 2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes | Q72436793 | ||
Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase | Q72457025 | ||
beta-Adrenergic Receptor Subtypes: Properties, Distribution, and Regulation | Q72466335 | ||
Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction | Q72472566 | ||
Human platelet α2-adrenergic receptors: Labeling with 3H-yohimbine, a selective antagonist ligand | Q72489898 | ||
Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists | Q72541789 | ||
Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart | Q72845240 | ||
Comparison of the action of isoproterenol and several related compounds on blood pressure, heart and bronchioles | Q72859630 | ||
Postsynaptic alpha adrenergic receptor subtypes differentiated by yohimbine in tissues from the rat. Existence of alpha-2 adrenergic receptors in rat aorta | Q72891576 | ||
Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release | Q35176494 | ||
Adrenergic Beta-Blocking Agents | Q35249946 | ||
THE ACTION OF EPINEPHRINE AND THE ROLE OF THE ADENYL CYCLASE SYSTEM IN HORMONE ACTION | Q35520689 | ||
The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function | Q35905267 | ||
Regulation of cyclic AMP formation in brain tissue by alpha-adrenergic receptors: requisite intermediacy of prostaglandins of the E series | Q36391106 | ||
In Vitro Study of beta-Adrenergic Receptors | Q36760272 | ||
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration | Q37021810 | ||
Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol | Q39090641 | ||
An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor | Q39090655 | ||
beta-Adrenergic receptors in rat brain | Q39098110 | ||
Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors | Q39118420 | ||
The role of calcium ions in accumulation of cyclic adenosine monophosphate elicited by alpha and beta adrenergic agonists in rat brain slices | Q39152050 | ||
Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors | Q39152626 | ||
A functional basis for classification of α-adrenergic receptors | Q39165904 | ||
Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function | Q39197588 | ||
Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic Therapy | Q39209687 | ||
Brain α-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex | Q39226025 | ||
Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by alpha-adrenergic receptors. I. Inhibition of adenylate cyclase mediated by alpha receptors | Q39239346 | ||
The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro | Q39270893 | ||
Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine | Q39270929 | ||
Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy | Q39588299 | ||
Cyclic GMP. | Q39873920 | ||
The role of cyclic AMP in the control of carbohydrate metabolism | Q39891830 | ||
Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals | Q39924718 | ||
Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro | Q39937728 | ||
Presynaptic regulation of catecholamine release | Q39953110 | ||
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). | Q39989705 | ||
Preferential blockade of presynaptic α-adrenoceptors by yohimbine | Q40026426 | ||
Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells | Q40033399 | ||
Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation | Q40066541 | ||
Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties | Q40085119 | ||
Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes | Q40085123 | ||
Phosphatidyldmositol hydrolysis: A multifunctional transducing mechanism | Q40085520 | ||
Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations | Q40086881 | ||
Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects | Q40103689 | ||
Elevated beta-adrenergic receptor number after chronic propranolol treatment | Q40104244 | ||
Effects of drugs on beta-adrenergic receptors on human lymphocytes | Q40106508 | ||
Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses | Q40119397 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1-15 | |
P577 | publication date | 1984-01-01 | |
P1433 | published in | Drugs | Q3040094 |
P1476 | title | Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation | |
??- and ??-Adrenergic Receptor Subtypes Properties, Distribution and Regulation | |||
P478 | volume | 28 Suppl 2 |
Q68304866 | A rapid high yield synthesis of no-carrier-added (-)-[123I]iodocyanopindolol |
Q57283584 | Adrb2 controls glucose homeostasis by developmental regulation of pancreatic islet vasculature |
Q60718622 | Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway |
Q47286476 | Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation. |
Q39267607 | Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks |
Q40835335 | Beta-adrenergic receptors support attention to extinction learning that occurs in the absence, but not the presence, of a context change |
Q26825047 | Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series) |
Q36676469 | Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease |
Q35096887 | Cellular magnesium homeostasis |
Q46241409 | Cerebral non-oxidative carbohydrate consumption in humans driven by adrenaline |
Q68086212 | Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats |
Q92376745 | Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink |
Q89726847 | Epinephrine responsiveness is reduced in livers from trained mice |
Q45100662 | Expression of α(1)-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT(2A) receptors |
Q55514857 | Function of Selective Neuromodulatory Projections in the Mammalian Cerebral Cortex: Comparison Between Cholinergic and Noradrenergic Systems. |
Q39260169 | Functional deprivation of noradrenaline neurotransmission: effects of clonidine on brain development |
Q92667871 | G protein-coupled receptor kinases as therapeutic targets in the heart |
Q59095759 | Hormonal control of Mg2+ transport in the heart |
Q60908782 | Influence of Beta-1 Adrenergic Receptor Genotype on Cardiovascular Response to Exercise in Healthy Subjects |
Q35755203 | Involvement of alpha-adrenoceptors in myometrial responses in the pro-oestral rat. |
Q99565007 | Locus coeruleus: a new look at the blue spot |
Q93081308 | Norepinephrine Inhibits Synovial Adipose Stem Cell Chondrogenesis via α2a-Adrenoceptor-Mediated ERK1/2 Activation |
Q34396286 | Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity |
Q89997470 | Phenylephrine induces relaxation of longitudinal strips from small arteries of goat legs |
Q37307260 | Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior |
Q89977044 | Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic kidney Diseases |
Q64107841 | Role of Norepinephrine in IL-1β-Induced Chondrocyte Dedifferentiation under Physioxia |
Q39148010 | Selective updates on mechanisms of action of positive inotropic agents |
Q92138562 | Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis |
Q48711248 | The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus |
Q35401594 | The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology |
Q38208293 | The role of prefrontal catecholamines in attention and working memory |
Q37408101 | Transformation of human ciliary epithelial cells by simian virus 40: induction of cell proliferation and retention of beta 2-adrenergic receptors |
Q89458910 | Urinary Norepinephrine Is a Metabolic Determinant of 24-Hour Energy Expenditure and Sleeping Metabolic Rate in Adult Humans |
Q36335513 | β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdala |
Search more.